To directly test this hypothesis, we have studied a Cav3.2 gain of function mutant at Met1549, recently identified in patients with hypertension due to primary aldosteronism (Scholl et al., 2015; Daniil et al., 2016). The gene discussed is CACNA1H; the disease is hypertensive disorder.